Follitropin alfa biosimilar - IVFarma

Drug Profile

Follitropin alfa biosimilar - IVFarma

Alternative Names: Primapur; r-hFSH - IVFarma

Latest Information Update: 06 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator iVFarma
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
  • Mechanism of Action Ovarian follicle modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Female infertility

Most Recent Events

  • 08 Feb 2017 Phase-III clinical trials in Female infertility in Russia (SC) (NCT03088137)
  • 26 Oct 2016 Ministry of Health of the Russian Federation approves IND application for follitropin alfa in Female infertility before February 2017 (NCT03088137)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top